Is protection by atorvastatin pretreatment in patients undergoing primary percutaneous coronary intervention associated with the lower levels of oxygen free radicals?
Atorvastatin can reduce oxygen free radicals developed in reperfusion, imposing protective effect on the myocardial cell during ischemic reperfusion injury.
Objective measurements of tissue volumes in AD demonstrated that WMH are significantly related to cortical atrophy and neuropsychological impairment.